Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_419a2f26739946e4eaf067d3efbcb2ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9d3d21155409ef5a0c72d9c9c3a0027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71df20ca02909a9dd88180764e927689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89eb65e42a4d709543375cf89cc57a44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef61a1f8c2be961dd62ceb0fec9ec18c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a2e81107d5f4d52fd2d91d851a8f4f8 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-61 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-61 |
filingDate |
2005-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ca8b56c162a3a1620a13fc1bf3485ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b7a04c7719380d66d441219f1c4d4eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e01d5735d9e6cc1d0ca5ee17469b2841 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea416277b39fe0596b437d884e568dd1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8920c21ed8dd564abeb645f8a41dd948 |
publicationDate |
2005-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005115461-A2 |
titleOfInvention |
Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
abstract |
Use of an inhibitor or activator of the triglyceride hydrolyse activity of a protein comprising a polypeptide strand encoded by the DNA sequence according to SEQ No. 1 for the preparation of a pharmaceutical composition for the treatment of medical disorders where it is desirable to modulate the activity of a protein encoded by the DNA sequence according to SEQ No. 1. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010115825-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2921270-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9914912-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014125110-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2956162-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010112569-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11312943-B2 |
priorityDate |
2004-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |